Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > XL184 Cabozantinib
XL184 Cabozantinib
Inquiry
| Post Date: | Aug 14,2013 |
| Expiry Date: | Feb 10,2014 |
| Detailed Description: | Cas No. :849217-68-1 Purity:99% |
| CAS Registry Number: | 849217-68-1 |
| Synonyms: | ;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;XL184;BMS-907351;Cabozantinib;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;1,1-cyclopropanedicarboxamide, n'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-n-(4-fluorophenyl)-; |
| Molecular Formula: | C28H24FN3O5 |
| Molecular Structure: | ![849217-68-1 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-](https://images.chemnet.com/suppliers/chembase/cas243/849217-68-1.gif)
|
| Company: | GuangZhou EastBang Pharmaceutical Science & Technology Co., Ltd. |
| Contact: | Zhu Chenglin |
| Tel: | 020-34706896/020-29073818 |
| Fax: | 020-34706729 |
| Email: | eastbang2006@hotmail.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
